Li-mou Zheng

发表

Tumor-targeted Salmonella expressing cytosine deaminase as an anticancer agent.

M. Belcourt, D. Bermudes, Stanley L. Lin, 2002, Human gene therapy.

Construction of VNP20009

J. Pawelek, K. B. Low, D. Bermudes, 2004 .

Construction of VNP20009: a novel, genetically stable antibiotic-sensitive strain of tumor-targeting Salmonella for parenteral administration in humans.

J. Pawelek, K. B. Low, D. Bermudes, 2004, Methods in molecular medicine.

Anti-tumor efficacy of Cloretazine (VNP40101M) alone and in combination with fludarabine in murine tumor and human xenograft tumor models

I. King, Zujin Li, Li-mou Zheng, 2007, Cancer Chemotherapy and Pharmacology.

Synthesis and application of sodium 2‐acrylamido‐2‐methylpropane sulphonate/N‐vinylcaprolactam/divinyl benzene as a high‐performance viscosifier in water‐based drilling fluid

Xiaodong Liu, Binqiang Xie, Huiqi Wang, 2016 .

Lipid A mutant Salmonella with suppressed virulence and TNFα induction retain tumor-targeting in vivo

Samuel I. Miller, Jessica Fischer, J. Platt, 1999, Nature Biotechnology.

Live bacteria as anticancer agents and tumor-selective protein delivery vectors.

D. Bermudes, I. King, Li-mou Zheng, 2002, Current opinion in drug discovery & development.

Comparative Evaluation of the Acute Toxic Effects in Monkeys, Pigs and Mice of a Genetically Engineered Salmonella Strain (VNP20009) Being Developed as an Antitumor Agent

Jessica Fischer, D. Bermudes, C. Clairmont, 2000 .

Tumour-Selective Salmonella-Based Cancer Therapy

M. Belcourt, J. Pawelek, K. B. Low, 2001, Biotechnology & genetic engineering reviews.

Use of preferentially replicating bacteria for the treatment of cancer.

M. Sznol, D. Bermudes, S. Lin, 2000, The Journal of clinical investigation.

Antitumor effect of VNP20009, an attenuated Salmonella, in murine tumor models.

X. Luo, D. Bermudes, T. Le, 2001, Oncology research.